Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Pediatrics
Published in: BMC Pediatrics 1/2018

Open Access 01-12-2018 | Research article

Racecadotril in the treatment of acute diarrhea in children: a systematic, comprehensive review and meta-analysis of randomized controlled trials

Authors: Marion Eberlin, Min Chen, Tobias Mueck, Jan Däbritz

Published in: BMC Pediatrics | Issue 1/2018

Login to get access

Abstract

Background

Racecadotril is a guideline-recommended option for the treatment of acute diarrhea in children but existing guidelines and previous reviews of the field are based on a small fraction of published evidence. Therefore, we have performed a systematic search for randomized controlled trials evaluating racecadotril as add-on or in comparison to other treatments.

Methods

A search was performed in PubMed, Scopus and Google Scholar without limits about country of origin or reporting language. A meta-analysis was conducted for the five most frequently used efficacy parameters.

Results

We have retrieved 58 trials, from nine countries including six in comparison to placebo, 15 in comparison to various active treatments and 41 as add-on to various standard treatments (some multi-armed studies allowing more than one comparison). Trials used 45 distinct efficacy parameters, most often time to cure, % of cured children after 3 days of treatment, global efficacy and number of stools on second day of treatment. Racecadotril was superior to comparator treatments in outpatients and hospitalized patients with a high degree of consistency as confirmed by meta-analysis for the five most frequently used outcome parameters. For instance, it reduced time to cure from 106.2 h to 78.2 h (mean reduction 28.0 h; P < 0.0001 in 24 studies reporting on this parameter). Tolerability of racecadotril was comparable to that of placebo (10.4% vs. 10.6% adverse events incidence) or that of active comparator treatments other than loperamide (2.4% in both groups).

Conclusions

Based on a comprehensive review of the existing evidence, we conclude that racecadotril is more efficacious than other treatments except for loperamide and has a tolerability similar to placebo and better than loperamide. These findings support the use of racecadotril in the treatment of acute diarrhea in children.
Literature
1.
2.
Guarino A, Ashkenazi S, Gendrel D, lo Vecchio A, Sharmir R, Szajewska H. European Society for Pediatric Gastroenterology, hepatology, and nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe. J Pediatr Gastroenterol Nutr. 2014;59:132–52.CrossRefPubMed
3.
4.
Lecomte JM. An overview of clinical studies with racecadotril in adults. Int J Antimicrob Agents. 2000;14(1):81–7.CrossRefPubMed
5.
6.
Schwartz JC. Racecadotril: a new approach to the treatment of diarrhoea. Int J Antimicrob Agents. 2000;14(1):75–9.CrossRefPubMed
7.
Eberlin M, Mück T, Michel MC. A comprehensive review of the pharmacodynamics, pharmacokinetics, and clinical effects of the neutral endopeptidase inhibitor racecadotril. Front Pharmacol. 2012;3:93.CrossRefPubMedPubMedCentral
8.
Lecomte JM, Costentin J, Vlaiculescu A, Chaillet P, Marcais-Collado H, Llorens-Cortes C, Leboyer M, Schwarz JC. Pharmacological properties of acetorphan, a parenterally active “enkephalinase” inhibitor. J Pharmacol Exp Ther. 1986;237(3):937–44.PubMed
9.
Lecomte JM, Baumer P, Lim C, Duchier J, Cournot A, Dussaule JC, Ardaillou R, Gros C, Chaignon B, Souque A, et al. Stereoselective protection of exogenous and endogenous atrial natriuretic factor by enkephalinase inhibitors in mice and humans. Eur J Pharmacol. 1990;179(1–2):65–73.CrossRefPubMed
10.
Turvill J, Farthing M. Enkephalins and enkephalinase inhibitors in intestinal fluid and electrolyte transport. Eur J Gastroenterol Hepatol. 1997;9(9):877–80.CrossRefPubMed
11.
Guarino A, Buccigrossi V, Armellino C. Colon in acute intestinal infection. J Pediatr Gastroenterol Nutr. 2009;48(Suppl 2):S58–62.CrossRefPubMed
12.
Primi MP, Bueno L, Baumer P, Berard H, Lecomte JM. Racecadotril demonstrates intestinal antisecretory activity in vivo. Aliment Pharmacol Ther. 1999;13(Suppl 6):3–7.CrossRefPubMed
13.
Hinterleitner TA, Petritsch W, Dimsity G, Berard H, Lecomte JM, Krejs GJ. Acetorphan prevents cholera-toxin-induced water and electrolyte secretion in the human jejunum. Eur J Gastroenterol Hepatol. 1997;9(9):887–91.CrossRefPubMed
14.
Marcais-Collado H, Uchida G, Costentin J, Schwartz JC, Lecomte JM. Naloxone-reversible antidearrheal effects of enkephalinase inhibitors. Eur J Pharmacol. 1987;144(2):125–32.CrossRefPubMed
15.
Baumer P, Akoue K, Bergmann JF, Chaussade S, Nepveux P, Alexandre CL, Schwartz JC, Lecomte JM. Acetorphan, a potent enkephalinase inhibitor, does not modify orocecal and colonic transit times in healthy subjects. Gastroenterol Clin Biol. 1989;13(11):947–8.PubMed
16.
Bergmann JF, Chaussade S, Couturier D, Baumer P, Schwartz JC, Lecomte JM. Effects of acetorphan, an antidiarrhoeal enkephalinase inhibitor, on oro-caecal and colonic transit times in healthy volunteers. Aliment Pharmacol Ther. 1992;6(3):305–13.CrossRefPubMed
17.
Baumer P, Danquechin Dorval E, Bertrand J, Vetel JM, Schwartz JC, Lecomte JM. Effects of acetorphan, an enkephalinase inhibitor, on experimental and acute diarrhoea. Gut. 1992;33:753–8.CrossRefPubMedPubMedCentral
18.
Duval-Ilfah Y, Barard H, Baumer P, Guillaume P, Raibaud P, Joulin Y, Lecomte MJ. Effects of racecadotril and loperamide on bacterial proliferation and on the central nervous system of the newborn gnotobiotic piglet. Aliment Pharmacol Ther. 1999;13(Suppl 6):9–14.
19.
Szajewska H, Ruszczynski M, Chmielewska A, Wieczorek J. Systematic review: racecadotril in the treatment of acute diarrhoea in children. Aliment Pharmacol Ther. 2007;26(6):807–13.CrossRefPubMed
20.
Emparanza Knörr JI, Ozcoidi Erro I, Martinez Andueza MC, Callen Blecua MT, Alustiza Martinez E, Asequinolaza Iparraguirre I. Systematic review of the efficacy of racecadotril in the treatment of acute diarrhoea. An Pediatr. 2008;69(5):432–8.CrossRef
21.
Hao R, de Vera M, Resurreccion E. Racecadotril in the traetment of acute diarrhea in children: a meta-analysis. PIDSP Journal. 2010;11(2):19–32.
22.
Lehert P, Cheron G, Calatayud GA, Cezard JP, Castrellon PG, Melendez Garcia JM, Santos M, Savitha MR. Racecadotril for childhood gastroenteritis: an individual patient data meta-analysis. Dig Liver Dis. 2011;43(9):707–13.CrossRefPubMed
23.
Gordon M, Akobeng A. Racecadotril for acute diarrhoea in children: systematic review and meta-analyses. Arch Dis Child. 2016;101(3):234–40.CrossRefPubMed
24.
Wu B, Li J, Fb W, Tang Y. Meta-analysis of therapeutic efficacy of racecadotril in the adjunctive treatment of acute infantile diarrhoea in China. China Pharm. 2012;23(18):1687–9.
25.
Gutierrez Castrelion P, Polanco Allue I, Salazar-Lindo E. An evidence based Iberic-Latin American guideline for acute gastroenteritis management in infants and prescholars. An Pediatr. 2010;73(3):220.e221–0.
26.
Fischbach W, Andresen V, Eberlin M, Mueck T, Layer P. A comprehensive comparison of the efficacy and tolerability of racecadotril with other treatments of acute diarrhea in adults. Front Pharmacol. 2016;3:44.
27.
Chacon J. Analysis of factors influencing the overall effect of racecadotril on childhood diarrhea. Results from a real-world and post-authorization surveillance study in Venezuela. Ther Clin Risk Manag. 2010;6:293–9.CrossRefPubMedPubMedCentral
28.
Gutierrez JA, Santo Sebastian M, Medina MC, Penalba Citores AC, Miguez Navarro MC, Maranon Pardillo R, Sanchez Sanchez C. Racecadotril en el tratamiento de pacientes ambulatorios con gastroenteritis aguda. An Pediatr. 2008;68(Suppl 2):104.
29.
Yang W, Hang G, Xu X, Yan J, Wu Y, Zhu Q, Qian Y. Clinical observation of racecadotril to treat infants and children with acute watery diarrhea. China Pract Pediatr J. 2006;21(12):945–6.
30.
Shi H, Jiang Y, An Q, Tang T. Clinical observation of racecadotril combined with dioctahedral montmorillonite in the treatment infantile rotavirus enteritis. Matern Child Healthcare China. 2008;23(22):3107–019.
31.
Ding YH. Clinical observation on the therapeutic effects of racecadotril granules combined with silliankang in the treatment of infantile rotaviral enteritis. J Chengde Med Coll. 2011;28(3):249–51.
32.
Bai C. Observation of combined application of changlekang and racecadotril granules in treating infantile diarrhea. Hebei Med. 2013;19(4):569–70.
33.
Alvarez Calatayud G, Pinel Simon G, Taboada Castro L, Santos Sebastian M, Rivas Castillo A, Abunaji Y, Leralta Fernandez M. Efectividad de racecadotrilo en el tratamiento de la gstroenteritis aguda. Acta Pediatr Esp. 2009;67(3):117–22.
34.
Santos M, Maranon R, Miguez C, Vazquez P, Sanchez C. Use of racecodatril as outpatient treatment for acute gastroenteritis: a prospective, randomized, parallel study. J Pediatr. 2009;155(1):62–7.CrossRefPubMed
35.
Morales Garcia JX. Eficacia de racecadotrilo en el tratamiento de la enfermedad diarreica aguda en niños de 3 a 36 meses en el servicio de emergencia del Hospital Vicente Corral Moscoso. Ensayo clínico controlado ciego. Master thesis. Cuenca: Universidad de Cuenca; 2014.
36.
Cojocaru B, Bocquet N, Timsit S, Wille C, Boursiquot C, Marcombes F, Garel D, Sannier N, Cheron G. Effect of racecadotril in the management of acute diarrhea in infants and children. Arch Pediatr. 2002;9(8):774–9.CrossRefPubMed
37.
Turck D, Berard H, Fretault N, Lecomte JM. Comparison of racecadotril and loperamide in children with acute diarrhoea. Aliment Pharmacol Ther. 1999;13(Suppl. 6):27–32.PubMed
38.
Cezard JP, Duhamel JF, Meyer M, Pharaon I, Bellaiche M, Maurage C, Ginies JL, Vaillant JM, Girardet JP, Lamireau T, et al. Efficacy and tolerability of racecadotril in acute diarrhea in children. Gastroenterology. 2001;120:799–805.CrossRefPubMed
39.
Gharial JS. Racecadotril for the treatment of severe acute watery diarrhoea in children admitted to the Kenyatta national hospital - a randomised double blinded placebo controlled trial: Aga Khan University; 2014.
40.
Salazar-Lindo E, Santisteban-Ponce J, Chea-Woo E, Gutierrez M. Racecadotril in the treatment of acute watery diarrhea in children. N Engl J Med. 2000;343(7):463–37.CrossRefPubMed
41.
Michael SSA, Ali AMA, Ezzat DA, Tayel SA. Evaluation of racecadotril in treatment of acute diarrhea in children. Asian J Pharm Clin Res. 2014;2(4):227–30.
42.
43.
Gutierrez-Castrellon P, Ortiz-Hernandez AA, Llamosas-Gallardo B, Acosta-Bastidas MA, Jiminez-Guierrez C, Diaz-Garcia L, Anzo-Osorio A, Estevez-Jimenez J, Jimenez-Escobar I, Vdal-Vaqquez RP. Efficacy of racecadotril versus smectite, probiotics or zinc as an integral part of treating acute diarrhoea in children under five: network meta-analysis. Gac Med Mex. 2015;151:329–37.PubMed
44.
Sun D, Xia Y, Dou X. Racecadotril in the treatment of moderate or severe acute watery diarrhea in infant. China Modern Doctor. 2007;45(4):9–10.
45.
Wang X-x, S-m L, H-y Y. To observe the efficacy of racecadotril granules in the treatment of infant with rotavirus enteritis. J Pediatr Pharm. 2007;13(2):4950.
46.
Guo H. Clinical observation of the application of racecadotril in the treatment of 48 cases of infantile diarrhea. China Med Herald. 2009;6(33):61–3.
47.
Su C. The observation of the efficacy of racecadotril to pediatric acute diarrhea. Jiangxi Med. 2006;41(8):676–7.
48.
Mao B, Wang BX. Observation of the efficacy of racecadotril plus smectite for treatment of pediatric acute non-infectious diarrhea. Huazhong Med J. 2008;32(5):347–9.
49.
Liu Y, Deng C, Wang W. Observation of the efficacy of racecadotril for treatment of 258 cases of infants and children with acute diarrhea. Inner Mongolia Med J. 2009;41(5):616–7.
50.
Pan Y. The clinical experience using racecadotril to treat 60 cases of pediatric acute diarrhea. Med Inf. 2011;2:567.
51.
Liu Z, Sun J, Tong J. The effect of racecadotril to treat infants and children with acute water diarrhea. Med J Qilu. 2007;22(6):493–4.
52.
Liu Z, Xu C-h, Jing Z, Yang Z-b. Treatment of racecadotril on rotavirus-enteritis in children. J Appl Clin Pediatr. 2007;22(19):1497–8.
53.
Hu J, Yang Y. Using racecadotril as assistant treatment for 60 cases of infants and children with acute watery diarrhea. Shanxi Med J. 2008;37(6):752–3.
54.
Huo K, Ma D. Observation of efficacy of racecadotril for treatment of infants and children with acute watery diarrhea. China J Misdiagnosis. 2008;8(9):2095–6.
55.
Qiu S. Effects of racecadotril on acute diarrhea of infants. Jiujang Med J. 2008;23(1):15–6.
56.
Zhu J, Wu B, Li J, Huang H, Tan W. Clinical observation of acute watery diarrhea in infants with racecadotril. Pharm Today. 2008;18(4):46–7.
57.
C-y P, He Z-k, You C. Effects of racecadotril on acute diarrhea of 125 infants. J Pediatr Pharm. 2009;15(5):26–7.
58.
Yan J, Shi Q. Observation of racecadotril granules in treating rotavirus enteritis in infants. China Pharm. 2009;18(3):57–8.
59.
Yu M. Observation of the effect of racecadotril to treat children suffering rotavirus intestitis. J Clin Med Pract. 2009;13(11):62–4.
60.
Yang H. Effects of racecadotril in 112 infants. China Hospital Pharm J. 2010;30(11):958–9.
61.
Zhou L. Observation of the efficacy of racecadotril to treat infants with acute diarrhea. Modern J Integr Tradition Chin West Med. 2010;19(7):816–7.
62.
Xiao Q. The effect of racecadotril in the treatment of infantile diarrhea: 88 cases curative effect observation. For all Health. 2011;5(5):20–1.
63.
G-y F. Effective observation of racecadotril in treating infantile acute water diarrhea. J Modern Med Health. 2012;28(2):175–6.
64.
Wang W. Curative effect of racecadotril in treatment of infantile rotavirus enteritis. J Pediatr Pharm. 2012;18(12):29–30.
65.
Wang L, Xiao Y. Clinical observation of racecadotril combined with smectite on rotavirus diarrhea in infants. Med J West China. 2010;22(6):1076–80.
66.
Chen Q, Zhang Y-q. Observation of racecadotril in treating acute watery diarrhea. J Modern Clin Med. 2009;35(6):427–8.
67.
Wang YX. Racecadotril in treating infantile diarrhea. J Shandong Med Coll. 2011;33:94–6.
68.
Geng M, Lu W. The comparison of therapeutic effects of children diarrhea treated with smecta and racecadotril granules. Harbin Med J. 2013;33(2):106–7.
69.
Fan Z, Chen M, Shen L. Observation of racecadotril granules in treating rotaviral enteritis in infants. J Pediatr Pharm. 2006;12(6):37–8.
70.
Xq H. Effect of racecadotril in 68 infants with rotavirus enteritis. Hebei Med. 2007;13(12):1259–61.
71.
Huang S, Cai X, Huang H. Clinical observation of treatment of acute rotaviral enteritis in infants with racecadotril granules. Mod Hosp. 2008;8(7):53–4.
72.
Bian J, Wang R, Zhang Q, Zhou X. Clinical effects of racecadotril granules and the impact on serum IL-1, L-8 and IL-12 levels in children with autumn diarrhea. Med J Wuhan Univ. 2012;33(3):384–6.
73.
Az C, Wang L, He L. Clinical efficacy of racecadotril granule in the treatment of acute infantile diarrhea. Jilin Med. 2011;32(14):2767–8.
74.
Liu J, Gao H, Feng W. Racecadotril granules combined with yam powder in the treatment of rotavirus enteritis. Tradition Chin Med. 2011;18(15):493–4.
75.
Fang HS, Wei CQ, Duan SC. Main content record of the National Diarrhoea Prevention and treatment symposium in 1988: new principle of diarrhoea treatment and supplement recommendation of therapeutic efficacy assessment criteria. Clin Pediatr J. 1988;16(5):358.
76.
Huang P, Chen R. Montmorillonite powder vs. racecadotril granule for acute infantile diarrhea: cost-minimization analysis. China Pharm. 2008;19(5):325–6.
77.
Cai Q. Observation of efficacy of racecadotril to treat infants with acute watery diarrhea. Med Clin. 2008;5(31):53–5.
78.
Wang X. Observation of efficacy of racecadotril to treat infants with acute diarrhea. Clin Med (Northfield Il). 2009;29(10):86–7.
79.
Wu L-b. Clinical observation of racecadotril granules in treatment for diarrhea in children. J Appl Clin Pediatr. 2007;22(5):335–58.
80.
Yang X. Efficacy analysis of racecadotril granules in the treatment of 42 cases of infantile rotavirus enteritis. J Qiannan Med Coll Nationalities. 2009;22(2):102.
81.
Ding L, Xf L. Observation of racecadotril in treating children with rotavirus enteritis. J Pediatr Pharm. 2010;16(4):30–1.
82.
Wang X-y, A-c Y, C-q H. Clinical observation of acute watery diarrhea in infants with racecadotril graules. Central South Pharm. 2007;5(4):372–3.
83.
Yao S, Zhang Y. Observation of efficacy of racecadotril in the treatment of 84 infants with acute watery diarrhea. Chin Commun Doct Med Profess. 2009;11(15):52.
84.
Melendez Garcia JM, Rodrigues JT. Racecadotril en el tratamiento de la dierra aguda en ninos. Rev Fac Med. 2007;4(1):25–8.
85.
Shen H. Observation of the therapeutic efficacy of racecadotril when combined with lactose-free dietary therapy to treat rotavirus enteritis. Clin Focus. 2011;26(13):1162–3.
86.
Russ SA, Larson K, Halfon N. A national profile of childhood epilepsy and seizure disorder. Pediatrics. 2012;129(2):256–64.CrossRefPubMed
87.
King CK, Glass R, Bresee JS, Duggan C. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR. 2003;52(RR-16):1–16.PubMed
88.
Guerrant RL, Van Gilder T, Steiner TS, Thielman NM, Slutsker L, Tauxe RV, Hennessy T, Griffin PM, DuPont H, Bradley Sack R, et al. Practice guidelines for the Management of Infectious Diarrhea. Clin Infect Dis. 2001;32(3):331–51.CrossRefPubMed
89.
90.
Yao P, Xi LL. Clinical effect of racecadotril tablets for acute diarrhea in adults. Chin J Clin Pharmacol. 2011;27(8):571–3.
91.
Vetel JM. Double-blind comparative study to evaluate the efficacy and tolerance of three doses of acetorphan versus placebo in the treatment of acute diarrhoea: Bioprojet; 1991. Edited by data on file, vol. Europe 90/08
92.
Hamza H, Khalifa HB, Baumer P, Berard H, Lecomte JM. Racecadotril versus placebo in the treatment of acute diarrhoea in adults. Aliment Pharmacol Ther. 1999;13(Suppl. 6):15–9.PubMed
93.
Coffin B, Rampal P. Double blind, randomized study of the efficacy of dexecadotril versus racecadotril and placebo, in the the symptomatic treatment of acute diarrhea. Study conducted in adult outpatients: Bioprojet; 2007. Edited by data on file, vol. P05-04/BP1.01
94.
Goldacre B. Bad Pharma. London: Fourth Estate; 2013.
95.
Andersson B, Caidahl K, di Lenarda A, Warren SE, Goss F, Waldenström A, Persson S, Wallentin I, Hjalmarson A, Waagstein F. Changes in early and late diastolic filling patterns by long-term adrenergic ß-blockade in patients with idiopathic dilated cardiomyopathy. Circulation. 1996;94:673–82.CrossRefPubMed
96.
Vesikari T, van Damme P, Giaquinto C, Dagan R, Guarino A, Szajewska H, Usonis V. European Society for Paediatric Infectious Diseases consensus recommendations for rotavirus vaccination in Europe. Update 2014. Pediatr Infect Dis J. 2015;34(6):635–43.CrossRefPubMed
97.
Guarino A, Albano F, Ashkenazi S, Gendrel D, Hoekstra JH, Shamir R, Szajewska H. European Society for Paedriatic Gastroenterology, hepatology, and nutrition/European Society for Paediatric Infections Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe. J Pediatr Gastroenterol Nutr. 2008;46(Suppl 2):S81–S184.CrossRefPubMed
98.
Roge J, Baumer P, Berard H, Schwartz JC, Lecomte JM. The enkephalinase inhibitor, acetorphan, in acute diarrhoea. A double-blind, controlled clinical trial versus loperamide. Scand J Gastroenterol. 1993;28:352–4.CrossRefPubMed
99.
Vetel JM, Berard H, Fretault N, Lecomte JM. Comparison of racecadotril and loperamide in adults with acute diarrhoea. Aliment Pharmacol Ther. 1999;13(Suppl. 6):21–6.PubMed
100.
Prado D. A multinational comparison of racecadotril and loperamide in the treatment of acute watery diarrhoea in adults. Scand J Gastroenterol. 2002;37:656–61.CrossRefPubMed
101.
Wang HH, Shieh MJ, Liao KF. A blind, randomized comparison of racecadotril and loperamide for stopping acute diarrhea in adults. World J Gastroenterol. 2005;11(10):1540–3.CrossRefPubMedPubMedCentral
102.
Hu R, Sun J. A multicentre, randomised, single-blind study to assess the efficacy and safety of racecadotril versus loperamide in the treatment of acute diarrhoea n adults: SmithKline Beecham (Tianjin) Co., Ltd; 2000. Edited by data on file, vol. SmithKline Beecham (Tianjin) Co., Ltd. Protocol 52607/006
103.
Coulden S, Graham J, Barlett J. A multicentric, randomised, single-blind, parallel group study to assess the efficacy, safety and tolerability of racecadotril (Hidrase TM ) 100 mg tid po versus loperamide 2.0 mg tid po in the treatment of acute diarrhoea in adults: SmithKline Beecham; 2001. Edited by data on file, vol. Document BRL-052607/RSD-101GL4/1
104.
Baumer P, Joulin Y. Pre- and postmarketing safety profiles of racecadotril sachets, a “new” antidiarrhoeal drug. J Pediatr Gastroenterol Nutr. 2009;48(Suppl 3):E99.
105.
Nelson JM, Griffin PM, Jones TF, Smith KE, Scallan E. Antimicrobial and antimotility agent use in persons with Shiga toxin-producing Escherischia coli O157 infection in FoodNet sites. Clin Infect Dis. 2011;52(9):1130–2.CrossRefPubMed
106.
Guarino A, Dupont C, Gorelov AV, Gottrand F, Lee JK, Lin Z, Lo Vecchio A, Nguyen TD, Salazar-Lindo E. The management of acute diarrhea in children in developed and developing areas: from evidence base to clinical practice. Expert Opin Pharmacother. 2012;13(1):17–26.CrossRefPubMed
107.
Tormo R, Polanco I, Salazar-Lindo E, Goulet O. Acute infectious diarrhoes in children: new insights in antisecretory treatment with racecadotril. Acta Paediatr. 2008;97(8):1008–15.CrossRefPubMed
108.
Saez J, Cifuentes L. Is racecadotril effective for acute diarrhea in children? Medwave. 2015;15(Suppl 3):e6339.CrossRef
Metadata
Title
Racecadotril in the treatment of acute diarrhea in children: a systematic, comprehensive review and meta-analysis of randomized controlled trials
Authors
Marion Eberlin
Min Chen
Tobias Mueck
Jan Däbritz
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2018
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-018-1095-x

Other articles of this Issue 1/2018

BMC Pediatrics 1/2018 Go to the issue

Study protocol

Does red blood cell irradiation and/or anemia trigger intestinal injury in premature infants with birth weight ≤ 1250 g? An observational birth cohort study

Case report

Case report of severe myocarditis in an immunocompromised child with Respiratory Syncytial Virus infection

Research article

Henoch-Schönlein purpura with acute pancreatitis: analysis of 13 cases

Research article

Patterns of early life body mass index and childhood overweight and obesity status at eight years of age

Research article

Burden and factors associated with clinical neonatal sepsis in urban Uganda: a community cohort study

Research article

Effect of increased enteral protein intake on plasma and urinary urea concentrations in preterm infants born at < 32 weeks gestation and < 1500 g birth weight enrolled in a randomized controlled trial – a secondary analysis